SEC Form 4 · accession 0001140361-17-013540
Skye Bioscience, Inc. · SKYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Reg Alexander Lapham
10% Owner
Period of report
Mar 13, 2017
Accepted (ET)
Mar 28, 2017 · 10:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 13, 2017 | X | 119,700 | $1.00 | D | 3,787,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of common stock were transferred to a creditor as repayment of outstanding principal and accrued interest of certain promissory note upon maturity pursuant to the terms of such note.